Dear Doctor Letter (Rote-Hand-Brief) on the use of intrauterine devices (IUDs): Risk of uterine perforation
2015.07.23
Active substance: levonorgestrel
In view of updated results of the "European Active Surveillance Study for Intrauterine Devices” (EURAS-IUD), the company Jenapharm GmbH & Co. KG is circulating information on the investigation of the use of copper-bearing intrauterine devices (Cu-IUDs) and levonorgestrel-releasing intrauterine systems (LNG-IUS).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN